Alec Van Gelder: Novo Nordisk Opens Global Patient Advocacy Role for Haemoglobinopathies
Alec Van Gelder, Vice President of Corporate Affairs, Rare Disease at Novo Nordisk, shared a post on LinkedIn:
“We’re Hiring: Associate Director, Patient Advocacy – Haemoglobinopathies at Novo Nordisk Rare Disease.
With recent progress in Sickle Cell Disease marking a pivotal moment for the haemoglobinopathy community, there has never been a more important time to help shape what comes next for patients.
We are looking for a passionate and experienced Associate Director of Patient Advocacy to partner with the haemoglobinopathies community and lead our global patient advocacy work — ensuring that the voices of those living with conditions like SCD and thalassemia sit at the very heart of Novo Nordisk’s access strategy and external engagement.
If you have a passion for improving the lives of people living with sickle cell disease and thalassemia, we would love to hear from you.
Apply now and be part of the story we are writing together with the haemoglobinopathy community.”
Stay updated with Hemostasis Today.
-
Nov 17, 2026, 23:45Cajetan Reichardt: LAAO vs. OAC in AF – Balancing Nonprocedural Bleeding and Ischemic Stroke Risk
-
Nov 17, 2026, 23:42Brian Tegtmeyer: Expanding Pre-Hospital Administration of Low-Titer O Positive Whole Blood
-
Nov 17, 2026, 23:41Mansi Kala: Advancing Hematology – From Evidence to Clinical Excellence
-
Nov 17, 2026, 23:40Nathan Connell: Registered for the WFH Comprehensive Care Summit 2027 in Prague
-
Nov 17, 2026, 23:38Yaariv Khaykin: Does Reducing AF Burden After Ablation Change the Need for Anticoagulation?
-
Nov 17, 2026, 23:38Amos Gitonga Mbaabu: Strengthening Care and Advocacy for Haemophilia and SCD across Southern Africa
-
Nov 17, 2026, 23:35Muhammad Sameed Altaf: A Decade of Working Together for Thalassemia Awareness and Patient Support
-
Nov 17, 2026, 23:34Ahmed Bennis: Is Aspirin Therapy Enough for VTE Prevention After Arthroplasty?
-
Nov 17, 2026, 23:33Remi Remakanth: The Role of Transfusion Medicine in HLA Antibody Testing and Transplant Desensitization